{"id":481268,"title":"Prescription Drug List (PDL): Remdesivir (COVID-19) notice - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-06","captureTimestamp":"2026-01-06T16:17:11.185000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/notice-prescription-drug-list-remdesivir-covid-19.html?wbdisable=true","snippet":"Prescription Drug List (PDL): Remdesivir (COVID-19) notice Date published: July 28, 2020 Our file number: 20-110364-67 The purpose of this Notice of Amendment is to notify about the addition of remdesivir to the Prescription Drug List (PDL) for human and veterinary use. The new…","rawSnapshotUrl":"/api/snapshots/raw/481268","browseUrl":"https://replay.healtharchive.ca/job-6/20260106161711/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/notice-prescription-drug-list-remdesivir-covid-19.html?wbdisable=true#ha_snapshot=481268","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}